Stay updated on Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial
Sign up to get notified when there's something new on the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page.

Latest updates to the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. This appears to be an internal version update with no changes to the study details or displayed information.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a Locations section highlighting Ohio as the study site (Columbus, Ohio) and updated the page revision to v3.3.3. The prior Ohio Locations reference and the HHS Vulnerability Disclosure link were removed (revision: v3.3.2).SummaryDifference0.2%

- Check54 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2; this is a routine site maintenance update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedRemoved the government funding lapse warning; study details and enrollment information remain the same with no new trial information added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check83 days agoChange DetectedNo substantial additions or deletions were detected; the study details page content remains unchanged aside from minor formatting adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check105 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference2%

Stay in the know with updates to Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page.